Maharashtra logs 3,320 new coronavirus cases, 61 deaths; active count 39,191

Of the 39,191 active patients in Maharashtra, Pune district has the highest at 9,807, a health department official said on September 23.

PTI

September 23, 2021 / 21:20 IST

Representative Image

Maharashtra on September 23 reported 3,320 COVID-19 cases and 61 deaths, which took its infection tally to 65,34,557 and toll to 1,38,725, a health department official said. With 4,050 patients getting discharged from hospitals in the last 24 hours, the recovery count rose to 63,53,079.

Maharashtra now has 39,191 active cases. The state has 2,61,842 people in home quarantine and another 1,461 in institutional quarantine, the official said.

The state's COVID-19 recovery rate now stands at 97.22 percent, while the fatality rate is 2.12 percent. The cumulative number of coronavirus tests conducted in the state climbed to 5,76,46,515 as 1,70,373 samples were examined in the last 24 hours, he said.

As many as eight districts – Dhule, Bhandara, Hingoli, Gondia, Nanded, Akola, Amravati, and Chandrapur – did not report any new COVID-19 infection. Similarly, Jalgaon, Parbhani, and Chandrapur municipal corporations (urban areas) also did not record any new coronavirus cases in the last 24 hours. Ahmednagar district reported the highest number of 577 new infections, followed by Mumbai city at 498. Satara district logged the highest fatalities in the state at 13.

Out of the eight regions in the state, the Pune region reported the highest number of new cases at 1,159, followed by 1,050 in the Mumbai region. The Nashik region reported 700 new cases, Kolhapur 251, Latur 104, Aurangabad 27, Nagpur 17, and Akola 12.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show